Author:
Himaki Takehiro,Masui Yumi,Chono Koji,Daikoku Tohru,Takemoto Masaya,Haixia Bo,Okuda Tomoko,Suzuki Hiroshi,Shiraki Kimiyasu
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A phase 3, randomized, double‐blind, placebo‐controlled study evaluating a single, patient‐initiated dose of amenamevir for recurrent herpes labialis;The Journal of Dermatology;2022-11-09
2. Single-Dose, Patient-Initiated Amenamevir Therapy for Recurrent Genital Herpes: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study;Open Forum Infectious Diseases;2022-09-22
3. SARS-CoV-2 helicase NSP13 hijacks the host protein EWSR1 to promote viral replication by enhancing RNA unwinding activity;Infectious Medicine;2022-03
4. Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster;Viruses;2021-08-05
5. Emergence of varicella-zoster virus resistance to acyclovir: epidemiology, prevention, and treatment;Expert Review of Anti-infective Therapy;2021-04-28